methylamine has been researched along with Breast Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ajloo, D; Divsalar, A; Eslami Moghadam, M; Hosaini Sadr, M; Shams Abyaneh, FS | 1 |
| Fominaya, J; Uherek, C; Wels, W | 1 |
2 other study(ies) available for methylamine and Breast Neoplasms
| Article | Year |
|---|---|
Improving of Anticancer Activity and Solubility of Cisplatin by Methylglycine and Methyl Amine Ligands Against Human Breast Adenocarcinoma Cell Line.
Topics: Adenocarcinoma; Antineoplastic Agents; Breast Neoplasms; Circular Dichroism; Cisplatin; DNA; Ethidium; Female; Humans; Ligands; MCF-7 Cells; Methylamines; Molecular Dynamics Simulation; Nucleic Acid Conformation; Sarcosine; Solubility; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Thermodynamics | 2018 |
A modular DNA carrier protein based on the structure of diphtheria toxin mediates target cell-specific gene delivery.
Topics: Ammonium Chloride; Animals; Anti-Bacterial Agents; Breast Neoplasms; Chloroquine; COS Cells; Diphtheria Toxin; Female; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Humans; Macrolides; Methylamines; Nigericin; Receptor, ErbB-2; Recombinant Fusion Proteins; Single-Chain Antibodies; Transfection; Tumor Cells, Cultured | 1998 |